XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

17,481 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 16,515
R4B: 4
R5: 438
R6: 0

Start Prev Rows 17400 - 17481

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.204	Unknown Glucose_Lab_Grouping	active	2023-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.524	UTI_Clinical Condition Grouping	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.540	bwell_Vital_Vital Signs Panel_Clinical Grouping Event	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.459	bwell_Vital_Waist Circumference_Clinical Grouping Event	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.617	bwell Combo Blood Pressure_UI	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.616	bwell Diastolic Blood Pressure_UI	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.615	bwell Systolic Blood Pressure_UI	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.626	b.well Herpes Zoster Vaccine CN_HD_Exclusions	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.627	b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.625	b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.622	b.well Herpes Zoster Vaccine CN_HD_2dose	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.618	b.well Herpes Zoster Vaccine CN_HD	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.1358	Beta lactam medicinal product SNOMED	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.224	Systolic Heart Failure I10	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1235.647	bwell Covid Vaccine CN_Allergy_SNOMED	active	2025-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.1354	Cefixime preparations for oral administration	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1	ONC Administrative Sex	active	2015-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.1352	Body weight	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.58	MMR Deficient	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.59	MMR Deficient	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.60	MMR Deficient	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1083	Central DXA of Hip or Spine	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.4467	Urogenital & Anorectal Specimens	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.87	Intrauterine Devices SNOMED Findings	active	2021-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1065	Chronic Liver Disease	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1067	Chronic Liver Disease	active	2022-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.4466	Pharyngeal specimens	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1097	Marfan's Syndrome	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.12.1009	Cushings Syndrome	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1085	Osteogenesis Imperfecta	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1087	Osteogenesis Imperfecta	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1088	Ankylosing Spondylitis	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1090	Ankylosing Spondylitis	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1091	Psoriatic Arthritis	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1093	Psoriatic Arthritis	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1096	Ehlers Danlos Syndrome	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1099	Marfan's Syndrome	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1100	Osteopenia	active	2018-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1102	Osteopenia	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1044	Osteogenesis Imperfecta	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1045	Ankylosing Spondylitis	active	2023-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1046	Psoriatic Arthritis	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1048	Marfan's Syndrome	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1049	Osteopenia	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1023	Cushings Syndrome	active	2021-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1025	Cushings Syndrome	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1026	Lupus	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1028	Lupus	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.12.1010	Lupus	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1068	Chronic Malnutrition	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1070	Chronic Malnutrition	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1036	Chronic Malnutrition	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.120	Patient Sex for Quality Measurement	active	2024-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1035	Chronic Liver Disease	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.1370	Beta lactam ingredients for allergy determination RXNORM	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.168	medications_COPD	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.40	MDP Test Intensional	active	2019-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.101.11.1281	Virtual Encounter	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.101.11.1282	Virtual Encounter	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.101.12.1089	Virtual Encounter	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.54	Planned Intervention moodCode	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.1.11.78	Observation Interpretation (HL7)	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.1.11.10267	ParticipationFunction	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.6.8	Severity	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1196.1344	Tests for Neisseria gonorrhoeae of unspecified site reported by presence	active	2024-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1099.4	DIRSectionTypeCodes LOINC	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.8	Intervention for Positive Utility Insecurity Screen	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.15	Intervention for Positive Transportation Insecurity Screen	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.13	Homelessness Diagnosis	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.11	Transportation Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.14	Housing Instability Diagnosis	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.9	Utility Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1170.12	Food Insecurity Diagnosis	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1021.33	Sexual Orientation	active	2021-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.80.68	Problem Status	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.60	Priority Level	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.65	Physical Exam Type	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.55	Goal Achievement	active	2024-06
fhir.outburn.co.il	R4	ValueSet/lrc-referral-codes	LRC Referral Codes	draft
fhir.outburn.co.il	R4	ValueSet/lrc-result-codes	LRC Result Codes	draft
fhir.outburn.co.il	R4	ValueSet/lrc-panel-result-codes	Lrc Panel Result Codes	draft